187 related articles for article (PubMed ID: 1944901)
21. Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: is there a biological explanation?
Shankar SK; Satishchandra P; Mahadevan A; Yasha TC; Nagaraja D; Taly AB; Prabhakar S; Nath A
J Neurovirol; 2003; 9 Suppl 1():59-67. PubMed ID: 12709874
[TBL] [Abstract][Full Text] [Related]
22. Progressive multifocal leukoencephalopathy in a patient with acquired immune deficiency syndrome.
Bernick C; Gregorios JB
Arch Neurol; 1984 Jul; 41(7):780-2. PubMed ID: 6743070
[TBL] [Abstract][Full Text] [Related]
23. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).
Antinori A; Cingolani A; Lorenzini P; Giancola ML; Uccella I; Bossolasco S; Grisetti S; Moretti F; Vigo B; Bongiovanni M; Del Grosso B; Arcidiacono MI; Fibbia GC; Mena M; Finazzi MG; Guaraldi G; Ammassari A; d'Arminio Monforte A; Cinque P; De Luca A;
J Neurovirol; 2003; 9 Suppl 1():47-53. PubMed ID: 12709872
[TBL] [Abstract][Full Text] [Related]
24. Drug-Induced Progressive Multifocal Leukoencephalopathy: A Comprehensive Analysis of the WHO Adverse Drug Reaction Database.
Melis M; Biagi C; Småbrekke L; Nonino F; Buccellato E; Donati M; Vaccheri A; Motola D
CNS Drugs; 2015; 29(10):879-91. PubMed ID: 26507833
[TBL] [Abstract][Full Text] [Related]
25. Post-cART progressive multifocal leukoencephalopathy era in a Brazilian center.
Lima MA; Silva MTT; Afonso LA; Vaz BJP
J Neurol Sci; 2017 Oct; 381():321-324. PubMed ID: 28991708
[TBL] [Abstract][Full Text] [Related]
26. [Progressive multifocal leukoencephalopathy as initial manifestation of acquired immunodeficiency].
de Lima MA; de Andrade FV; Etchebehere RM; Silva-Vergara ML
Rev Soc Bras Med Trop; 1998; 31(6):569-74. PubMed ID: 9859703
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.
Antinori A; Ammassari A; Giancola ML; Cingolani A; Grisetti S; Murri R; Alba L; Ciancio B; Soldani F; Larussa D; Ippolito G; De Luca A
J Neurovirol; 2001 Aug; 7(4):323-8. PubMed ID: 11517411
[TBL] [Abstract][Full Text] [Related]
28. Detection of JC virus infection in progressive multifocal leukoencephalopathy: the first documented case in Thailand.
Dujneungkunakorn T; Sungkanuparph S; Vibhagool A; Pairoj W; Chantratita W; Srichunrusami C; Laothamatas J; Pulkes T
J Med Assoc Thai; 2002 Oct; 85(10):1139-44. PubMed ID: 12501908
[TBL] [Abstract][Full Text] [Related]
29. PML--update.
Crit Path AIDS Proj; 1994-1995 Winter; (No 30):28-9. PubMed ID: 11362157
[TBL] [Abstract][Full Text] [Related]
30. Mortality attributable to HIV infection/AIDS--United States, 1981-1990.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1991 Jan; 40(3):41-4. PubMed ID: 1898757
[TBL] [Abstract][Full Text] [Related]
31. [Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome].
Clavo Sánchez A; García-Gil D; Sasián Martínez S; Geraldía Lama M; Serrano González A; Bascuñana Quirell A
Rev Clin Esp; 1994 Jan; 194(1):13-6. PubMed ID: 8153407
[TBL] [Abstract][Full Text] [Related]
32. Incidence of progressive multifocal leukoencephalopathy in patients without HIV.
Amend KL; Turnbull B; Foskett N; Napalkov P; Kurth T; Seeger J
Neurology; 2010 Oct; 75(15):1326-32. PubMed ID: 20938025
[TBL] [Abstract][Full Text] [Related]
33. Acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome: prevalence, main characteristics, and outcomes in a Brazilian center.
Santana MN; Ferrari R; Macedo AC; Marcusso RMN; Fernandes RA; Vidal JE
Arq Neuropsiquiatr; 2023 Oct; 81(10):883-890. PubMed ID: 37899047
[TBL] [Abstract][Full Text] [Related]
34. [Clinical investigation of the 8 cases with AIDS (acquired immunodeficiency syndrome)-associated progressive multifocal leukoencephalopathy (PML)].
Arai N; Kishida S; Yoritaka A; Ohta K
Rinsho Shinkeigaku; 2005 Feb; 45(2):89-95. PubMed ID: 15782605
[TBL] [Abstract][Full Text] [Related]
35. The reporting of HIV/AIDS deaths in women.
Buehler JW; Hanson DL; Chu SY
Am J Public Health; 1992 Nov; 82(11):1500-5. PubMed ID: 1443300
[TBL] [Abstract][Full Text] [Related]
36. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab.
Berger JR; Houff S
Neurol Res; 2006 Apr; 28(3):299-305. PubMed ID: 16687057
[TBL] [Abstract][Full Text] [Related]
37. Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient.
Stoner GL; Agostini HT; Ryschkewitsch CF; Mazló M; Gullotta F; Wamukota W; Lucas S
J Med Microbiol; 1998 Aug; 47(8):733-42. PubMed ID: 9877195
[TBL] [Abstract][Full Text] [Related]
38. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV.
Tassie JM; Gasnault J; Bentata M; Deloumeaux J; Boué F; Billaud E; Costagliola D
AIDS; 1999 Oct; 13(14):1881-7. PubMed ID: 10513646
[TBL] [Abstract][Full Text] [Related]
39. [Clinico-epidemiologic manifestations of progressive multifocal leukoencephalopathy in patients with acquired immunodeficiency syndrome (AIDS)].
Iglesias Oliva L; Nan D; García-Palomo JD; Fariñas MC
An Med Interna; 2000 Apr; 17(4):178-81. PubMed ID: 10893767
[TBL] [Abstract][Full Text] [Related]
40. Progressive multifocal leukoencephalopathy (PML) in AIDS.
Neurology; 1988 Dec; 38(12):1897. PubMed ID: 3194070
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
